Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Nanoviricides, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 25 | 31 | +6 |
| Shares | 1.11M | 1.33M | +216.1K (+19.4%) |
| Value | $2.09M | $2.30M | +$207.5K (+9.9%) |
New holders (9)
Institutions that held Nanoviricides, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 42,334 | $73.0K | 0.00% |
| Citadel Advisors LLC | 35,889 | $62.0K | 0.00% |
| Two Sigma Investments, LP | 34,193 | $59.0K | 0.00% |
| Susquehanna International Group, LLP | 15,936 | $28.0K | 0.00% |
| Two Sigma Securities, LLC | 14,246 | $25.0K | 0.00% |
| Simplex Trading, LLC | 14,129 | $24.0K | 0.00% |
| Asset Dedication, LLC | 1,450 | $3.00K | 0.00% |
| Royal Bank of Canada | 1 | $0 | 0.00% |
| Gradient Investments LLC | 49 | $0 | 0.00% |
Sold out (3)
Institutions that held Nanoviricides, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 2,251 | $4.00K |
| Cutler Group LP | 1,100 | $2.00K |
| Prospera Financial Services Inc | 450 | $1.00K |